Skip to Main Content
FIB-SEM Collaboration Core (F-SCC)
YSM Home

INFORMATION FOR

Nikolai Podoltsev, MD, PhD

Associate Professor of Internal Medicine (Hematology)
DownloadHi-Res Photo

Additional Titles

Duffy Firm Chief for Education, Department of Internal Medicine

Associate Director of the Hematology/Oncology Fellowship Program, Department of Internal Medicine

Clinical Director, Malignant Hematology, Department of Internal Medicine, Division of Malignant Hematology

About

Titles

Associate Professor of Internal Medicine (Hematology)

Duffy Firm Chief for Education, Department of Internal Medicine; Associate Director of the Hematology/Oncology Fellowship Program, Department of Internal Medicine; Clinical Director, Malignant Hematology, Department of Internal Medicine, Division of Malignant Hematology

Biography

Dr. Nikolai Podoltsev is an Associate Professor of Medicine (Hematology). His practice is focused on management of patients with acute leukemias, including acute myeloid leukemias (AML) and acute lymphoblastic leukemia (ALL) as well as myeloid neoplasms like myelodisplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs), such as polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), and chronic myeloid leukemia (CML) among others. He also provides care for patients with aplastic anemia and bone marrow failure syndromes and follows patients with clonal hematopoiesis of indeterminate potential (CHIP), and systemic mastocytosis and hypereosinophilic syndrome. He is the director of the Hematology/Leukemia Tumor Board.

As the Associate Director of the Yale Hematology/Oncology Fellowship Program and Yale-New Haven Hospital Duffy Firm Chief for Education, Dr. Podoltsev is involved in organizing and providing hematology education for hematology/medical oncology fellows, internal medicine residents, and medical students. The Yale Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center membership helps Dr. Podoltsev to study epidemiology, and the patterns of care and outcomes of patients with hematological malignancies. Dr. Podoltsev is engaged in the clinical research programs of the Leukemia Clinical Research Team as a Principal Investigator for multiple clinical trials enrolling patients with acute leukemias and myeloid malignancies.

Appointments

  • Hematology

    Associate Professor on Term
    Primary
    Hematology

Other Departments & Organizations

Education & Training

Fellow
Yale University School of Medicine (2010)
Chief Resident
Hospital of St Raphael (2001)
Resident
Hospital of St Raphael (2000)
Fellow
St. Petersburg State Pavlov Medical University (1997)
PhD
Pavlov First State Medical University of St. Petersburg (1997)
Resident
St. Petersburg State Pavlov Medical University (1995)
MD
Pavlov First State Medical University of St. Petersburg (1993)

Research

Overview

Management of Malignant Hematology - Older Adult Focus; Myeloprolipherative Neoplasms

Medical Subject Headings (MeSH)

Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders

Research at a Glance

Yale Co-Authors

Frequent collaborators of Nikolai Podoltsev's published research.

Publications

2024

See All Publications

Clinical Trials

Current Trials

Academic Achievements & Community Involvement

  • honor

    Yale Cancer Center Award for Clinical Excellence

    Yale School of Medicine Award
  • honor

    The David S. Fischer, MD Annual Award for Outstanding Teaching and Mentoring in Hematology

    Yale School of Medicine AwardYale Cancer Center
  • honor

    The David S. Fischer, MD Annual Award for Outstanding Teaching and Mentoring in Hematology

    Yale School of Medicine AwardYale Cancer Center
  • honor

    The David S. Fischer, MD Annual Award for Outstanding Teaching and Mentoring in Hematology

    Yale School of Medicine AwardYale Cancer Center

Clinical Care

Overview

Nikolai Podoltsev, MD, PhD, is a hematologist who specializes in treating patients with acute leukemias, or cancers of the blood and bone marrow. These include acute myeloid leukemias, acute lymphoblastic leukemia, myeloid neoplasms, myeloproliferative neoplasms, and chronic myeloid leukemia.

Dr. Podoltsev also cares for patients with aplastic anemia and bone marrow failure syndromes and those with clonal hematopoiesis of indeterminate potential (CHIP), systemic mastocytosis, and hypereosinophilic syndrome. He is the director of the Hematology/Leukemia Tumor Board and represents Yale Cancer Center on National Comprehensive Cancer Network (NCCN) clinical practice guidelines panels, including the Myeloproliferative Neoplasms Panel.

Dr. Podoltsev says he appreciates the relationships he forms with patients and their families. “I enjoy helping them improve their quality of life and taking off the burden of stress when they know they are in the excellent care of our dedicated team,” he says.

Part of the Leukemia Disease Aligned Research Team (DART), Dr. Podoltsev is a principal investigator for multiple clinical trials enrolling patients with acute leukemias and myeloid malignancies.

“We have a number of clinical trials that are investigating drugs that might change the course of many malignant diseases and offering clinical trials is an important part of our mission,” he says.

Clinical Specialties

Hematologic Oncology; Leukemia & Lymphoma

Fact Sheets

See All Fact Sheets On Yale Medicine

Yale Medicine News

See All News On Yale Medicine

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Get In Touch

Contacts

Email
Appointment Number
Clinic Fax Number

Administrative Support

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

    See Patient Care Locations